The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026) US Smoking Cessation: Your Gateway to the $24.8B NRT Market The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what